Deals
Dealmakers Are in Last-Minute $70 Billion M&A Rush Before Holidays
- Amgen, Thoma Bravo announce major deals as year-end nears
- Late flurry of activity is rare bright spot in dismal 2022
This article is for subscribers only.
Dealmakers racing to get transactions across the line before the holidays have finalized nearly $70 billion of mergers and acquisitions this week.
Biotech giant Amgen Inc. is leading the flurry of transactions, saying Monday it will buy Horizon Therapeutics Plc for $28 billion in the year’s biggest health-care deal to add drugs for rare disorders. Thoma Bravo announced a takeover of business-spend management platform Coupa Software Inc. for $8 billion including debt, confirming a Bloomberg News report.